The inverse correlation between serum of anti-pneumococcal and ferritin levels after pneumococcal vaccination in splenectomised beta thalassemia major
Resumen
Splenectomy is necessary in beta thalassemia major (BTM) patients when the spleen develops hyperactive which leading to extreme destruction of erythrocytes. This study assessed the ferritin effect on serum pneumococcal antibody (APA) response following of pneumococcal vaccination in patients with BTM after splenectomy. In this case series study, convenience sampling was used to recruit 347 SBT patients under the auspices of Jahrom University of Medical Sciences. Demographic data such as age, sex, and time after splenectomy were recorded by a questionnaire. All participants have been splenectomised and received a dose of pneumococcal vaccine 14 days before surgery. The IgG antibody responses to pneumococcal vaccine and levels of serum specific ferritin were determine by commercial enzyme immunoassay kits. For the analysis, we used SPSS software version 16. A p-value less than 0.05 were considered statistically significant. More participants (63.4%) were hypo-responder to pneumococcal vaccine. Also, serum APA was related to Post splenectomy duration (PSD) and serum ferritin (p< 0.001) but not to gender (p> 0.05). An important result was a relation of serum APA to serum ferritin according to PSD groups. Therefore, in three groups of PSD, the serum ferritin was higher in hypo-responder than in good responder subjects. Our results indicate that serum anti-pneumococcal IgG antibody decreased with increment of serum ferritin and PSD. Thus, there is a need to re-address the approach towards revaccination in this immune-compromised group of patients by administering a booster pneumococcal vaccination in an attempt to recover immunity and reduce morbidity.Derechos de autor 2022 Karamatollah Rahmanian, Masihollah Shakeri, Vahid Rahmanian, Shahryiar Najafi-Tireh Shabankareh, Fatemeh Sotoodeh Jahromi, Abdolreza Sotoodeh Jahromi
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0.
VacciMonitor es una revista de libre acceso, bajo licencia Creative Commons. La revista permite reutilizar su contenido acorde a: https:/creativecommons.org/licenses/by/4.0/deed.es.
Concede a los autores los permisos siguientes:
-Tener la propiedad total del copyright sin restricciones.
-Distribuir copias, electrónicas o impresas, del artículo publicado entre sus estudiantes o colegas, así como permiso para que los demás miembros de su institución las utilicen con propósitos de enseñanza.
-Reutilizar parte o la totalidad del artículo en nuevos manuscritos o libros futuros.
-VacciMonitor no pone reparos en que el autor coloque su versión, o la editada por la revista, en su sitio web personal o en un repositorio de acceso abierto.
-VacciMonitor autoriza a otras casas editoriales o bases de datos a reproducir los materiales originales publicados en ella, siempre que se indique su procedencia.
